Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 857.25
-31.00 (-3.49%)
Aug 1, 2025, 3:29 PM IST
CTI BioPharma Revenue
In the fiscal year ending March 31, 2025, Shilpa Medicare had annual revenue of 12.86B INR with 11.56% growth. Shilpa Medicare had revenue of 3.31B in the quarter ending March 31, 2025, with 12.72% growth.
Revenue
12.86B
Revenue Growth
+11.56%
P/S Ratio
5.78
Revenue / Employee
12.77M
Employees
1,007
Market Cap
74.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.86B | 1.33B | 11.56% |
| Mar 31, 2024 | 11.53B | 1.01B | 9.64% |
| Mar 31, 2023 | 10.52B | -952.56M | -8.31% |
| Mar 31, 2022 | 11.47B | 2.45B | 27.21% |
| Mar 31, 2021 | 9.02B | -66.41M | -0.73% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.86B |
Shilpa Medicare News
- 17 days ago - Shilpa Medicare shares jump nearly 5% after USFDA issues EIR with VAI for Bengaluru unit - Business Upturn
- 4 weeks ago - Shilpa Medicare subsidiary clears GMP inspection from ANVISA with no major observations - Business Upturn
- 2 months ago - Antique cuts target on Shilpa Medicare to Rs 1,090, retains ‘Buy’ on long-term monetization potential - Business Upturn
- 2 months ago - Top stocks to watch today, May 27: Lupin, Aurobindo Pharma, NHPC, KEC International, Shilpa Medicare and more - Business Upturn
- 2 months ago - Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe - Business Upturn
- 2 months ago - Shilpa Medicare shares climb nearly 4% after USFDA EIR for subsidiary, gains European GMP nod for biologics unit - Business Upturn
- 3 months ago - Shilpa Medicare’s Bengaluru facility secures GMP approval from EMA for Oral Mouth Dissolving Films and Transdermal Systems - Business Upturn
- 3 months ago - Shilpa Medicare shares jump 3% after arm gets EU GMP clearance for Dharwad plant - Business Upturn